Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 6 (neurotransmitter transporter), member 3 | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 6 (neurotransmitter transporter), member 2 | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 6 (neurotransmitter transporter), member 4 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Sodium:neurotransmitter symporter family protein | solute carrier family 6 (neurotransmitter transporter), member 3 | 620 aa | 579 aa | 33.2 % |
Brugia malayi | Sodium:neurotransmitter symporter family protein | solute carrier family 6 (neurotransmitter transporter), member 2 | 617 aa | 638 aa | 32.5 % |
Brugia malayi | Sodium:neurotransmitter symporter family protein | solute carrier family 6 (neurotransmitter transporter), member 4 | 630 aa | 574 aa | 31.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0292 | 0.5 | 0.5 | |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0292 | 0.5 | 0.5 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0292 | 0.5 | 0.5 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0292 | 0.5 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0292 | 0.5 | 0.5 |
Loa Loa (eye worm) | serotonin transporter b | 0.0292 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0.5 | 0.5 |
Echinococcus granulosus | serotonin transporter | 0.0292 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0.5 | 0.5 |
Echinococcus multilocularis | serotonin transporter | 0.0292 | 0.5 | 0.5 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0292 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 32 nM | Inhibition of [3H]serotonin reuptake at human SERT expressed in HEK cells | ChEMBL. | 19201198 |
IC50 (binding) | = 61 nM | Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells | ChEMBL. | 19201198 |
IC50 (binding) | = 313 nM | Inhibition of [3H]dopamine reuptake at human DAT expressed in HEK cells | ChEMBL. | 19201198 |
Ki (binding) | = 1105 nM | Displacement of [125I]RTI55 from human SERT expressed in HEK cells | ChEMBL. | 19201198 |
Ki (binding) | = 1106 nM | Displacement of [125I]RTI55 from human NET expressed in HEK cells | ChEMBL. | 19201198 |
Ki (binding) | = 6830 nM | Displacement of [125I]RTI55 from human DAT expressed in HEK cells | ChEMBL. | 19201198 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.